Literature DB >> 21959128

Decreased benzodiazepine receptor and increased GABA level in cortical tubers in tuberous sclerosis complex.

Kenji Mori1, Tatsuo Mori, Yoshihiro Toda, Emiko Fujii, Masahito Miyazaki, Masafumi Harada, Shoji Kagami.   

Abstract

PURPOSE: To elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (TSC), proton magnetic resonance spectroscopy ((1)H-MRS) and [123I] iomazenil (123I-IMZ) single photon emission computed tomography (SPECT) were performed.
METHODS: (1)H-MRS using a clinical 3-tesla magnetic resonance imager was performed in four children with TSC and 10 age-and sex-matched healthy control subjects. A single voxel was set on the right parietal lobe in control subjects. In patients with TSC, a single voxel was set on the epileptogenic tuber in the parietal or temporal lobe, and another voxel was set on the contralateral normal-appearing brain region. N-Acetylaspartate (NAA), myo-Inositol (mIns) and Glutamate (Glu) were analyzed using a conventional STEAM (Stimulated Echo Acquisition Mode) method. The concentration of gamma-aminobutyric acid (GABA) was quantified using MEGA-Point Resolved Spectroscopy (PRESS). Interictal 123I-IMZ SPECT was examined in all four patients with TSC.
RESULTS: A significant decrease in the NAA concentration and significant increases in the mIns and GABA concentrations were detected in the cortical tubers of all 4 patients. No significant difference was observed in Glu concentrations. In all of the cortical tubers detected by magnetic resonance imaging, 123I-IMZ binding was significantly decreased.
CONCLUSION: Epileptogenesis in TSC might be caused by decreased inhibition secondary to the decrease in GABA receptors in dysplastic neurons of cortical tubers. An increase in the GABA concentration may compensate for decreased inhibition.
Copyright © 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959128     DOI: 10.1016/j.braindev.2011.09.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  10 in total

Review 1.  mTOR inhibition in epilepsy: rationale and clinical perspectives.

Authors:  Adam P Ostendorf; Michael Wong
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

2.  Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions.

Authors:  Jurriaan M Peters; Maxime Taquet; Anna K Prohl; Benoit Scherrer; Agnies M van Eeghen; Sanjay P Prabhu; Mustafa Sahin; Simon K Warfield
Journal:  Future Neurol       Date:  2013-09

3.  Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label Study.

Authors:  Erika L Juarez-Martinez; Dorinde M van Andel; Jan J Sprengers; Arthur-Ervin Avramiea; Bob Oranje; Floortje E Scheepers; Floor E Jansen; Huibert D Mansvelder; Klaus Linkenkaer-Hansen; Hilgo Bruining
Journal:  Front Neurosci       Date:  2022-05-12       Impact factor: 5.152

Review 4.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

5.  Early neurodevelopmental screening in tuberous sclerosis complex: a potential window of opportunity.

Authors:  Tanjala T Gipson; Gwendolyn Gerner; Siddharth Srivastava; Andrea Poretti; Rebecca Vaurio; Adam Hartman; Michael V Johnston
Journal:  Pediatr Neurol       Date:  2014-05-04       Impact factor: 3.372

6.  Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.

Authors:  Helen S Bateup; Caroline A Johnson; Cassandra L Denefrio; Jessica L Saulnier; Karl Kornacker; Bernardo L Sabatini
Journal:  Neuron       Date:  2013-05-08       Impact factor: 17.173

7.  Neuron-Glia Interactions in Tuberous Sclerosis Complex Affect the Synaptic Balance in 2D and Organoid Cultures.

Authors:  Stephanie Dooves; Arianne J H van Velthoven; Linda G Suciati; Vivi M Heine
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

Review 8.  Molecular Imaging of Brain Tumor-Associated Epilepsy.

Authors:  Csaba Juhász; Sandeep Mittal
Journal:  Diagnostics (Basel)       Date:  2020-12-05

Review 9.  Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism.

Authors:  Anastasia Neklyudova; Kirill Smirnov; Anna Rebreikina; Olga Martynova; Olga Sysoeva
Journal:  Genes (Basel)       Date:  2022-04-11       Impact factor: 4.141

10.  Hyperexcitability of the local cortical circuit in mouse models of tuberous sclerosis complex.

Authors:  Jian-Ping Zhao; Akira Yoshii
Journal:  Mol Brain       Date:  2019-01-25       Impact factor: 4.041

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.